Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

RedHill Biopharma (RDHL) Asset Utilization Ratio (2016 - 2023)

RedHill Biopharma has reported Asset Utilization Ratio over the past 11 years, most recently at 0.76 for Q2 2023.

  • Quarterly Asset Utilization Ratio rose 69.8% to 0.76 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 0.76 through Jun 2023, up 69.8% year-over-year, with the annual reading at 0.01 for FY2025, 96.63% down from the prior year.
  • Asset Utilization Ratio was 0.76 for Q2 2023 at RedHill Biopharma, up from 0.48 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.76 in Q2 2023 and troughed at 0.05 in Q1 2020.
  • The 5-year median for Asset Utilization Ratio is 0.39 (2021), against an average of 0.34.
  • Year-over-year, Asset Utilization Ratio plummeted 59.38% in 2020 and then surged 712.54% in 2021.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.11 in 2019, then skyrocketed by 234.97% to 0.37 in 2020, then grew by 26.61% to 0.47 in 2021, then decreased by 16.2% to 0.39 in 2022, then skyrocketed by 94.75% to 0.76 in 2023.
  • Per Business Quant, the three most recent readings for RDHL's Asset Utilization Ratio are 0.76 (Q2 2023), 0.48 (Q1 2023), and 0.39 (Q4 2022).